eHealth (NASDAQ:EHTH) Price Target Lowered to $5.00 at UBS Group

Key Points

• UBS Group has lowered eHealth's price target from $7.00 to $5.00, indicating a "neutral" rating with a potential upside of 34.23% from its previous close.
• eHealth's stock has declined by 21.7%, trading at $3.73 and has recently seen increased trading volume compared to its average.
• Institutional ownership of eHealth is significant, with 79.54% of the stock held by institutional investors and hedge funds, reflecting confidence in the company's long-term potential.

eHealth (NASDAQ:EHTH - Get Free Report) had its price target reduced by investment analysts at UBS Group from $7.00 to $5.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage presently has a "neutral" rating on the financial services provider's stock. UBS Group's target price would suggest a potential upside of 34.23% from the company's previous close.

A number of other analysts have also weighed in on the stock. Wall Street Zen lowered shares of eHealth from a "buy" rating to a "hold" rating in a research note on Sunday, May 11th. Royal Bank Of Canada reiterated a "sector perform" rating and set a $11.00 price target on shares of eHealth in a report on Monday, May 19th. Four equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $6.25.

eHealth Stock Down 21.7%

Shares of eHealth stock traded down $1.04 during trading on Thursday, reaching $3.73. The company's stock had a trading volume of 905,488 shares, compared to its average volume of 367,274. The company has a 50-day simple moving average of $4.02 and a two-hundred day simple moving average of $6.22. eHealth has a 1-year low of $3.18 and a 1-year high of $11.36. The company has a market cap of $112.98 million, a price-to-earnings ratio of -3.78 and a beta of 1.06.

eHealth (NASDAQ:EHTH - Get Free Report) last released its earnings results on Wednesday, May 7th. The financial services provider reported ($0.33) EPS for the quarter, topping analysts' consensus estimates of ($0.41) by $0.08. eHealth had a net margin of 4.14% and a return on equity of 2.16%. The company had revenue of $113.12 million during the quarter, compared to analysts' expectations of $99.46 million. As a group, analysts anticipate that eHealth will post -2.17 earnings per share for the current year.

Institutional Trading of eHealth

Institutional investors and hedge funds have recently made changes to their positions in the stock. R Squared Ltd purchased a new position in shares of eHealth during the 2nd quarter worth $47,000. Graham Capital Management L.P. acquired a new stake in shares of eHealth in the fourth quarter worth approximately $110,000. Prudential Financial Inc. purchased a new stake in eHealth in the fourth quarter valued at approximately $111,000. Cannon Global Investment Management LLC purchased a new position in eHealth during the first quarter worth approximately $121,000. Finally, Quantbot Technologies LP purchased a new stake in shares of eHealth during the 1st quarter valued at $121,000. 79.54% of the stock is currently owned by hedge funds and other institutional investors.

eHealth Company Profile

eHealth, Inc operates a health insurance marketplace that provides consumer engagement, education, and health insurance enrollment solutions in the United States. The company operates in two segments, Medicare; and Employer and Individual. The Medicare segment offers sale of Medicare-related health insurance plans, which includes Medicare advantage, Medicare Supplement, and Medicare Part D prescription drug plans to Medicare-eligible customers including but not limited to, dental, and vision insurance, as well as advertising program for marketing and other services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.